Previous studies showed that B cells and CD4+ T cells are required for induction of a murine retrovirus-induced immunodeficiency syndrome, murine AIDS. Using B6 mice deficient in mature B cells as a result of a knockout of the transmembrane exon of the immunoglobulin M gene, we found that spleen and other tissues from murine AIDS virus-infected mice did not express the defective virus (BM5def) required for induction of disease, even though helper viruses were readily detectable and BM5def proviral DNA was present. This indicates that the B-lineage cells are the primary targets for infection and expression of the defective virus and that in the absence of mature B cells, there is ineflicient infection of T cells and macrophages.
Infection of susceptible strains of mice, such as C57BL/6 (B6), with the LP-BM5 mixture of murine leukemia viruses (MuLVs) induces a syndrome of severe immunodeficiency and progressive lymphoproliferation termed murine AIDS (MAIDS) (11, 17) . The immunodeficiency involves defects in T cells, B cells, and macrophages (17) , while B cells are the predominant proliferative population (10, 13) . The disease is a consequence of complex host-virus interactions that are only partially understood. Induction of MAIDS requires the presence of CD4+ T cells (20) and B cells (2) and expression of the MA and p12 portions (18) of the gag gene of replicationdefective viruses designated BM5def (3, 4) or Du5H (1) . MAIDS can be induced by helper-free defective virus (9) , but in disease induced by the LP-BM5 virus mixture, nonpathogenic, replication-competent ecotropic and mink cell focusforming (MCF) viruses serve as helpers for cell-to-cell transmission of the defective genome and are known to accelerate development of disease (4, 18) .
At present, the extent to which abnormalities of various cell types can be ascribed to direct effects of BM5def on infected cells is not known. It has been suggested that B cells are the major targets for infection by defective viruses in mice infected helper free (10) , although studies of mice infected with the virus mixture showed that peritoneal macrophages (5) and T cells (14, 19) , as well as B cells (4, 8, 13, 19) , can serve as targets for infection and expression of BM5def.
In the present study, we evaluated the targets for BM5def following mixed-virus infection by first determining the levels of defective virus mRNA in various spleen cell subsets at different times after infection. For these analyses, B cells, T cells (CD4+ plus CD8+), and macrophages were purified from spleens by positive selection by using magnetic cell separation techniques (16) followed by single-cell sorting. Flow cytometry (fluorescence-activated cell sorter) (FACS) studies of purified cells showed that 98% or more expressed the selected phenotype (data not shown). Semiquantitative reverse transcription-PCR (RT-PCR) analyses of these preparations (Fig. 1) (6) . Considerably higher levels of expression were detected with mRNA from cells of mice infected for 2 weeks or more. At each time point cells were examined, the levels of expression were lower for T cells than for B cells, while expression in macrophages was closer to the levels in B cells than to those in T cells. These studies showed that splenic as well as peritoneal Mac-1+ cells (5) are targets for expression of BM5def and that macrophages from spleens expressed levels of defective virus approximating those in B cells.
The studies that revealed a requirement for B cells in MAIDS had utilized mice made B cell deficient by treatment from birth with anti-immunoglobulin M (IgM) antibodies (2) . This treatment regimen is difficult to maintain long-term and precludes the use of B-cell reconstitution experiments to further dissect the role of B cells in disease. To overcome these problems, we studied mice with a B-cell deficiency due to a targeted mutation of the membrane exon of the IgM heavy chain gene (12) . B-cell development in homozygous mutant mice is arrested at the pre-B-cell stage of maturation, and mature B cells are undetectable (12) .
Mice derived from the fifth-or sixth-generation backcross to normal B6 mice were intercrossed to yield homozygous mutant (B6 ,uMT-'-) and control (B6 -,MT`') mice. Infected heterozygous mice developed MAIDS with a time course like that for normal B6 mice (data not shown), indicating that residual genetic contributions to this strain derived from MAIDS-resistant 129 mice (17) producing infectious ecotropic and MCF viruses were generally higher for B6 mice than for B6 ,uwMT`mice (Table 1) .
These results differed from those of earlier studies of anti-IgMtreated mice, which revealed comparable expression of both classes of helper virus in spleens of control and B-cell-deficient animals (2). The basis for the differences in helper virus recovery from mice rendered B cell deficient by genetic manipulation versus injection of anti-IgM antibodies is not certain. The monoclonal antibody-treated mice have macrophages filled with immune complexes and are undergoing chronic antigenic stimulation with the rabbit anti-IgM antibody used for B-cell suppression. The knockout mice simply lack B cells and experience less insult to other components of the immune system. These distinctions between the models may account for the differences in helper virus expression.
To determine if the B-cell deficiency also affected expression of BM5def, we used a semiquantitative RT-PCR analysis of viral transcripts. Strikingly, spleens (Fig. 2) , lymph nodes, and thymuses (data not shown) from mutant mice failed to exhibit transcripts for the defective virus when examined at any of a series of time points from 1 to 15 weeks postinfection, while increasing levels of expression were detected in spleens of nonmutant B6 mice (Fig. 2) . In agreement with the data from the infectious center tests, the levels of ecotropic virus expression were lower in spleens of B6 ,uMT`mice than in spleens of nonmutant controls.
DNA PCR analyses of BM5def proviral sequences (Fig. 3 ) showed the defective genome to be present at high levels in spleens of B6 mice infected for as little as 1 week but to be below the levels of detection in spleens of mutant mice until 6 weeks postinfection. On prolonged exposures of the same blot, signals of BM5def-related sequences were found at extremely low levels at the earlier time points (data not shown).
Although unlikely, it was formally possible that mutant mice might carry strain 129 genes linked to the mutant Ig heavychain locus that could inhibit spread and expression of defective virus and induction of disease when present in the homozygous state in B6* puMT-/-mice. To In view of the substantial levels of helper virus expression, it is quite remarkable that non-B cells in the mutants do not express the defective virus, especially since infection of both T cells and macrophages is readily detectable in nonmutant mice by 1 week postinfection ( Fig. 1) and by DNA PCR in the mutant mice by 6 weeks (Fig. 3) . Lack of T-cell and macrophage activation in the infected mutant mice may limit potential targets for productive infection, since integration of murine retroviruses is dependent on cell proliferation (15) . This seems unlikely, however, since no BM5def transcripts were detected in mutant mouse thymuses, lymphoid compartments with high cell turnover, while high levels were present in the thymuses of B6 mice infected for 3 weeks (data not shown).
The demonstration that the mutant mice can be reconstituted with normal B cells should provide an opportunity to determine if specific subsets of B cells are particularly important to induction of MAIDS. It was reported that CD5+ (B-la) cells are expanded in infected B6 mice and that they express BM5def at higher levels than do conventional B cells (8) .
Selective B-cell reconstitution experiments using B6 -,uMTm ice should provide an opportunity to further explore this issue.
